Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-25-000994

Director sold 10,960 shares at $12.52 ($137,219)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

SATO VICKI L · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-01-08 Sale : show line 1 in the form 10b5-1 −10,960 $12.52 $137,219 1,312,391 D
Open-market sales · 10,960 sh · avg $12.52 · $137,219
Loading xslF345X05/wk-form4_1736384620.xml…